ツイートする Facebook にシェア

ABT-202

From Wikipedia, the free encyclopedia

Jump to: navigation, search
ABT-202
Systematic (IUPAC) name
(3S)-1-(pyridin-3-yl)pyrrolidin-3-amine
Identifiers
ATC code  ?
PubChem CID 39220800
ChemSpider 16397614 YesY
Chemical data
Formula C9H13N3 
Mol. mass 163.219
SMILES eMolecules & PubChem
Therapeutic considerations
Pregnancy cat.  ?
Legal status
 YesY(what is this?)  (verify)

ABT-202 is a drug developed by Abbott, which acts as an agonist at neural nicotinic acetylcholine receptors and has been researched for use as an analgesic, although it has not passed clinical trials.[1][2]

References

  1. ^ Jain, KK (2004). "Modulators of nicotinic acetylcholine receptors as analgesics". Current opinion in investigational drugs (London, England : 2000) 5 (1): 76–81. PMID 14983978.  edit
  2. ^ Romanelli, M.; Gratteri, P.; Guandalini, L.; Martini, E.; Bonaccini, C.; Gualtieri, F. (2007). "Central nicotinic receptors: structure, function, ligands, and therapeutic potential". ChemMedChem 2 (6): 746–767. doi:10.1002/cmdc.200600207. PMID 17295372.  edit




gooウェブ検索 急上昇ランキング (総合)
Wikipedia記事検索について

This page is based on the copyrighted Wikipedia article ( ABT-202 ); it is used under the GNU Free Documentation License. You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.